Serotonin antagonists new class antiemetic agents number significant advances past decade prevention treatment chemotherapy-induced emesis formidable problems cisplatin-containing regimens third patients high-dose cisplatin substantial emesis available conventional antiemetics toxic effects agents troublesome recent years new class agents serotonin antagonists agents promise clinical utility wide range areas Selective antagonists serotonin type receptor early clinical trials potent antiemetic agents patients cytotoxic chemotherapy efficacy comparable conventional antiemetics Toxic effects date receptor antagonists modest current state knowledge respect agents antiemetics patients cytotoxic chemotherapy 